Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    1701519 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis
Condition: Breast Neoplasms
Intervention:
2 Completed
Has Results
Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma
Conditions: Ovarian Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Drug: Pemetrexed;   Drug: Bevacizumab
3 Unknown  Safety Study of Bevacizumab to Treat Women With a History of Breast Cancer and Suffering From Upper Extremity Lymphedema
Condition: Lymphedema
Intervention: Drug: Bevacizumab
4 Active, not recruiting Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot Study
Condition: Breast Cancer
Intervention:

Indicates status has not been verified in more than two years